June 14 (Reuters) - Sirtex Medical Ltd (SRX) :
- TERMINATES VARIAN SCHEME & ENTERS INTO A BINDING SCHEME IMPLEMENTATION DEED WITH CDH GENETECH AND CHINA GRAND PHARMA
- UNANIMOUSLY FORMED VIEW THAT CDH-CGP PROPOSAL IS SUPERIOR TO PROPOSED SCHEME OF ARRANGEMENT WITH VARIAN
- CDH & CHINA GRAND PHARMACEUTICAL AND HEALTHCARE HOLDINGS WILL BUY 100% OF SHARES IN SIRTEX FOR A$33.60 IN CASH PER SIRTEX SHARE
- BOARD UNANIMOUSLY RECOMMENDS SIRTEX SHAREHOLDERS VOTE IN FAVOUR OF CDH- CGP SCHEME
- REQUIRED TO PAY A BREAK FEE TO VARIAN OF ABOUT A$16 MLN AS A RESULT OF SIRTEX BOARD SUPPORTING CDH-CGP SCHEME
- BOARD INTENDS TO VOTE SHARES IN THEIR CONTROL IN FAVOUR OF PROPOSED CDH-CGP SCHEME
- TERMINATES VARIAN SCHEME & ENTERS INTO A BINDING SCHEME IMPLEMENTATION DEED WITH CDH GENETECH AND CHINA GRAND PHARMA
June 14 (Reuters) - Sirtex Medical Ltd (SRX) : TERMINATES...
Add to My Watchlist
What is My Watchlist?